# Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage

> **NCT01252160** · PHASE4 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 306 (actual)

## Conditions studied

- Neuralgia, Postherpetic

## Interventions

- **DRUG:** QUTENZA

## Key facts

- **NCT ID:** NCT01252160
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10-28
- **Primary completion:** 2013-09-26
- **Final completion:** 2013-09-26
- **Target enrollment:** 306 (ACTUAL)
- **Last updated:** 2018-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01252160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01252160, "Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01252160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*